Correlation of p53 and Ki-67 (MIB-1) expressions with clinicopathological features and prognosis of early stage cervical squamous cell carcinomas

Journal of Obstetrics and Gynaecology Research

Volumn 36, Issue 3, 2010, Pages 572-580

  Hanprasertpong, Jitti ^a   Tungsinmunkong, Kobkul ^a   Chichareon, Saibua ^a   Wootipoom, Virach ^a   Geater, Alan ^a   Buhachat, Rakchai ^a   Boonyapipat, Sathana ^a  

^a PRINCE OF SONGKLA UNIVERSITY   (Thailand)

Author keywords

Cervical cancer; Ki 67; MIB 1; P53; Prognosis; Squamous cell carcinoma

Indexed keywords

KI 67 ANTIGEN; PROTEIN P53;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PROGNOSIS; PROTEIN EXPRESSION; RADICAL HYSTERECTOMY; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX; CARCINOMA, SQUAMOUS CELL; DISEASE FREE SURVIVAL; HYSTERECTOMY; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; UTERINE CERVICAL NEOPLASMS;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; KI-67 ANTIGEN; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; TUMOR SUPPRESSOR PROTEIN P53; UTERINE CERVICAL NEOPLASMS;

EID: 77953346754     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2010.01227.x     Document Type: Article

References (30)

1. Ferenczy A, Franco E. Persistent human papillomavirus infection and cervical neoplasia. Lancet Oncol 2002 3 : 11 16.
2. Stanley MA. Human papillomavirus and cervical carcinogenesis. Best Pract Res Clin Obstet Gynaecol 2001 15 : 663 676.
3. Levine AJ, Momand J, Finlay CA. The p53 tumour suppressor gene. Nature 1991 351 : 453 456.
4. Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science 1991 253 : 49 53.
5. Ichiyoshi Y, Oiwa H, Tomisaki S et al. Overexpression of p53 is associated with growth pattern and prognosis in advanced gastric cancer. Hepatogastroenterology 1997 44 : 546 553.
6. Soong R, Knowles S, Williams KE, Hammond IG, Wysocki SJ, Iacopetta BJ. Overexpression of p53 protein is an independent prognostic indicator in human endometrial carcinoma. Br J Cancer 1996 74 : 562 567.
7. Naidu R, Yadav M, Nair S, Kutty KK. Immunohistochemical analysis of p53 expression in primary breast carcinomas. Anticancer Res 1998 18 : 65 70. (Pubitemid 28174686)
8. Ebara T, Mitsuhashi N, Saito Y et al. Prognostic significance of immunohistochemically detected p53 protein expression in stage IIIB squamous cell carcinoma of the uterine cervix treated with radiation therapy alone. Gynecol Oncol 1996 63 : 216 218.
9. Oka K, Suzuki Y, Nakano T. Expression of p27 and p53 in cervical squamous cell carcinoma patients treated with radiotherapy alone: Radiotherapeutic effect and prognosis. Cancer 2000 88 : 2766 2773.
10. De Jonge ET, Viljoen E, Lindeque BG, Amant F, Nesland JM, Holm R. The prognostic significance of p53, mdm2, c-erbB-2, cathepsin D, and thrombocytosis in stage IB cervical cancer treated by primary radical hysterectomy. Int J Gynecol Cancer 1999 9 : 198 205.
11. Shiohara S, Shiozawa T, Miyamoto T et al. Expression of cyclins, p53, and Ki-67 in cervical squamous cell carcinomas: Overexpression of cyclin A is a poor prognostic factor in stage Ib and II disease. Virchows Arch 2005 446 : 626 633.
12. Brenna SM, Zeferino LC, Pinto GA et al. P53 expression as a predictor of recurrence in cervical squamous cell carcinoma. Int J Gynecol Cancer 2002 12 : 299 303.
13. Hahn WC, Weinberg RA. Rules for making human tumor cells. N Engl J Medical 2002 347 : 1593 1603.
14. Kritpracha K, Hanprasertpong J, Chandeying V, Dechsukhum C, Geater A. Survival analysis in advanced epithelial ovarian carcinoma in relation to proliferative index of MIB-1 immunostaining. J Obstet Gynaecol Res 2005 31 : 268 276.
15. Scagliotti GV, Micela M, Gubetta L et al. Prognostic significance of Ki67 labelling in resected non small cell lung cancer. Eur J Cancer 1993 29 : 363 365.
16. Shrestha ML, Miyake H, Kikutsuji T, Tashiro S. Prognostic significance of Ki-67 and p53 antigen expression in carcinomas of bile duct and gallbladder. J Med Invest 1998 45 : 95 102.
17. Ho DM, Hsu CY, Chiang H. MIB-1 labeling index as a prognostic indicator for survival in patients with FIGO stage IB squamous cell carcinoma of the cervix. Gynecol Oncol 2000 76 : 97 102.
18. Graflund M, Sorbe B, Bryne M, Karlsson M. The prognostic value of a histologic grading system, DNA profile, and MIB-1 expression in early stages of cervical squamous cell carcinomas. Int J Gynecol Cancer 2002 12 : 149 157.
19. Lane DP. Cancer. A death in the life of p53. Nature 1993 362 : 786 787.
20. Jain D, Srinivasan R, Patel FD, Kumari Gupta S. Evaluation of p53 and Bcl-2 expression as prognostic markers in invasive cervical carcinoma stage IIb/III patients treated by radiotherapy. Gynecol Oncol 2003 88 : 22 28.
21. Riou G, Favre M, Jeannel D, Bourhis J, Le Doussal V, Orth G. Association between poor prognosis in early-stage invasive cervical carcinomas and non-detection of HPV DNA. Lancet 1990 335 : 1171 1174. (Pubitemid 20171367)
22. Steben M, Duarte-Franco E. Human papillomavirus infection: Epidemiology and pathophysiology. Gynecol Oncol 2007 107 (2 Suppl S2 S5.
23. Tungsinmunkong K, Suwiwat S, Sriplung H. Detection of human papillomavirus in intraepithelial lesions and carcinoma of the cervix uteri in southern Thai women. Asian Pac J Cancer Prev 2006 7 : 427 430.
24. Wootipoom V, Lekhyananda N, Phungrassami T, Boonyaphiphat P, Thongsuksai P. Prognostic significance of Bax, Bcl-2, and p53 expressions in cervical squamous cell carcinoma treated by radiotherapy. Gynecol Oncol 2004 94 : 636 642.
25. Graflund M, Sorbe B, Karlsson M. Immunohistochemical expression of p53, bcl-2, and p21(WAF1/CIP1) in early cervical carcinoma: Correlation with clinical outcome. Int J Gynecol Cancer 2002 12 : 290 298.
26. Avall-Lundqvist EH, Silfversward C, Aspenblad U, Nilsson BR, Auer GU. The impact of tumour angiogenesis, p53 overexpression and proliferative activity (MIB-1) on survival in squamous cervical carcinoma. Eur J Cancer 1997 33 : 1799 1804.
27. Huang LW, Chou YY, Chao SL, Chen TJ, Lee TT. p53 and p21 expression in precancerous lesions and carcinomas of the uterine cervix: Overexpression of p53 predicts poor disease outcome. Gynecol Oncol 2001 83 : 348 354.
28. Meyer JS. Cell kinetic measurement in human tumors. Human Pathol 1982 13 : 874 877.
29. Garzetti GG, Ciavattini A, Lucarini G et al. MIB 1 immunostaining in stage I squamous cervical carcinoma: Relationship with natural killer cell activity. Gynecol Oncol 1995 58 : 28 33.
30. Van De Putte G, Kristensen GB, Lie AK, Baekelandt M, Holm R. Cyclins and proliferation markers in early squamous cervical carcinoma. Gynecol Oncol 2004 92 : 40 46. (Pubitemid 38147369)